Results for “ ”

Entry Author Date Location
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. 08/30/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation 08/28/19 San Francisco
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud 08/21/19 San Francisco
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No. 08/16/19 San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Mason Raises $25M to Help Software Firms Deploy, Manage Applications 08/14/19 Seattle
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Ford, Retreating From Bold Timeline, Buys Quantum Signal for AV Tech 08/01/19 San Francisco
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
White House Floats Canadian Import Plan But Excludes Many Costly Drugs 07/31/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data 07/26/19 Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
No Co-Founder? Y Combinator Offers Matchmaking at Startup School 07/26/19 San Francisco
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown 07/25/19 National
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
With Regulator’s Nod, Bosch Plans Spread of Driverless Valet Parking 07/23/19 San Francisco
Could Facebook’s Crypto Break Financial System? Congress Airs Fears 07/19/19 San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Page 2 of 119 « previous page · next page »